Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.

Cardiovascular Research
Bagrov AYaE P Zhabko

Abstract

The aim was to look for the presence of circulating factor(s) with Na,K-ATPase inhibitory properties and digoxin like immunoreactivity in patients after acute myocardial infarction. Venous blood samples were obtained when the patients were admitted and different methods were used to monitor the plasma concentrations of factor(s) with properties of digitalis. SUBJECTS - These were 26 patients of both sexes (mean age 57.7 years, range 40-72) during the first 24 h of a first transmural acute myocardial infarct, 11 male patients with unstable angina pectoris (52.5 years, 45-67), and 18 healthy male controls (25 to 50 years). There was significant inhibition of ouabain sensitive Na,K-ATPase in intact erythrocytes in patients with myocardial infarction [1.4(SEM 0.15)mumol Pi.mg-1.h-1] compared with patients with unstable angina pectoris [3.1(0.4), p less than 0.01] and healthy controls [3.4(0.25), p less than 0.01]. In myocardial infarction complicated by ventricular fibrillation (n = 5) Na,K-ATPase activity was significantly lower than in the other 21 patients [0.95(0.2) and 1.55(0.11) mumol Pi.mg-1.h-1 respectively, p less than 0.05]. There was no change in erythrocyte Na,K-ATPase activity in myocardial infarction complicated by ac...Continue Reading

Citations

May 25, 2002·European Journal of Biochemistry·Wilhelm Schoner
Oct 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Iva Dostanic-LarsonJerry B Lingrel
Dec 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Isabel LarreMarcelino Cereijido
Jan 1, 1994·Journal of Internal Medicine·A Y BagrovO V Fedorova
Mar 28, 2009·Pharmacological Reviews·Alexei Y BagrovOlga V Fedorova
Oct 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jack H Kaplan
Aug 1, 1994·Kidney International·R G WoolfsonH E de Wardener
Jun 1, 2016·Medical Hypotheses·Kanwarjeet S BrarRif S El-Mallakh
Oct 1, 2011·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A S PadilhaF D M Siman
Jul 6, 2007·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Wilhelm Schoner, Georgios Scheiner-Bobis
Feb 10, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Iva Dostanic-LarsonJerry B Lingrel
Feb 10, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Patrizia FerrariGiuseppe Bianchi
May 15, 2007·American Journal of Physiology. Cell Physiology·Wilhelm Schoner, Georgios Scheiner-Bobis
Nov 4, 2011·American Journal of Physiology. Cell Physiology·M CereijidoI Larre
Jul 1, 1995·Psychosomatic Medicine·D E AndersonJ L Austin
Aug 28, 2014·Journal of Cardiovascular Pharmacology·Fabiana D M SimanAlessandra S Padilha
Jul 1, 1996·Molecular and Cellular Biochemistry·F Kölbel, V Schreiber
Mar 13, 2010·American Journal of Therapeutics·Mayank K MittalAnand Chockalingam
Apr 13, 2019·Insects·Rif S El-MallakhRajashekar Reddy Yeruva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.